These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 25301725)

  • 1. Characterization of single disseminated prostate cancer cells reveals tumor cell heterogeneity and identifies dormancy associated pathways.
    Chéry L; Lam HM; Coleman I; Lakely B; Coleman R; Larson S; Aguirre-Ghiso JA; Xia J; Gulati R; Nelson PS; Montgomery B; Lange P; Snyder LA; Vessella RL; Morrissey C
    Oncotarget; 2014 Oct; 5(20):9939-51. PubMed ID: 25301725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection and isolation of disseminated tumor cells in bone marrow of patients with clinically localized prostate cancer.
    Cackowski FC; Wang Y; Decker JT; Sifuentes C; Weindorf S; Jung Y; Wang Y; Decker AM; Yumoto K; Szerlip N; Buttitta L; Pienta KJ; Morgan TM; Taichman RS
    Prostate; 2019 Oct; 79(14):1715-1727. PubMed ID: 31449673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor removal limits prostate cancer cell dissemination in bone and osteoblasts induce cancer cell dormancy through focal adhesion kinase.
    Liu R; Su S; Xing J; Liu K; Zhao Y; Stangis M; Jacho DP; Yildirim-Ayan ED; Gatto-Weis CM; Chen B; Li X
    J Exp Clin Cancer Res; 2023 Oct; 42(1):264. PubMed ID: 37821954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time to metastatic relapse and breast cancer cells dissemination in bone marrow at metastatic relapse.
    Bidard FC; Vincent-Salomon A; Sigal-Zafrani B; Rodrigues M; Diéras V; Mignot L; Sastre-Garau X; Poupon MF; Pierga JY
    Clin Exp Metastasis; 2008; 25(8):871-5. PubMed ID: 18989740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The biology and clinical implications of prostate cancer dormancy and metastasis.
    Morrissey C; Vessella RL; Lange PH; Lam HM
    J Mol Med (Berl); 2016 Mar; 94(3):259-65. PubMed ID: 26489605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mer Tyrosine Kinase Regulates Disseminated Prostate Cancer Cellular Dormancy.
    Cackowski FC; Eber MR; Rhee J; Decker AM; Yumoto K; Berry JE; Lee E; Shiozawa Y; Jung Y; Aguirre-Ghiso JA; Taichman RS
    J Cell Biochem; 2017 Apr; 118(4):891-902. PubMed ID: 27753136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of disseminated tumor cells in locally advanced breast cancer patients before primary systemic therapy.
    Solá M; Margelí M; Castellá E; Cirauqui B; Mariscal A; Rull M; Julian JF; Luna M; Vallejo V; Fraile M
    Breast; 2013 Oct; 22(5):908-13. PubMed ID: 23683695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein signatures associated with tumor cell dissemination in head and neck cancer.
    Bleijerveld OB; Brakenhoff RH; Schaaij-Visser TB; Damen JM; Altelaar AF; Heck AJ; Leemans CR; Slijper M
    J Proteomics; 2011 Apr; 74(4):558-66. PubMed ID: 21262401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urokinase-plasminogen-activator receptor expression in disseminated tumour cells in the bone marrow and peripheral blood of patients with clinically localized prostate cancer.
    Thomas C; Wiesner C; Melchior SW; Schmidt F; Gillitzer R; Thüroff JW; Pfitzenmaier J
    BJU Int; 2009 Jul; 104(1):29-34. PubMed ID: 19154451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical Changes in the Niche Following Tumor Cell Invasion.
    Decker AM; Cackowski FC; Jung Y; Taichman RS
    J Cell Biochem; 2017 Aug; 118(8):1956-1964. PubMed ID: 27982511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse.
    Bidard FC; Vincent-Salomon A; Gomme S; Nos C; de Rycke Y; Thiery JP; Sigal-Zafrani B; Mignot L; Sastre-Garau X; Pierga JY;
    Clin Cancer Res; 2008 Jun; 14(11):3306-11. PubMed ID: 18519757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of a novel unfolded protein response phenotype of cancer stem/progenitor cells from the bone marrow of breast cancer patients.
    Bartkowiak K; Effenberger KE; Harder S; Andreas A; Buck F; Peter-Katalinic J; Pantel K; Brandt BH
    J Proteome Res; 2010 Jun; 9(6):3158-68. PubMed ID: 20423148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular Adhesion Promotes Prostate Cancer Cells Escape from Dormancy.
    Ruppender N; Larson S; Lakely B; Kollath L; Brown L; Coleman I; Coleman R; Nguyen H; Nelson PS; Corey E; Snyder LA; Vessella RL; Morrissey C; Lam HM
    PLoS One; 2015; 10(6):e0130565. PubMed ID: 26090669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone Metastasis: Molecular Mechanisms Implicated in Tumour Cell Dormancy in Breast and Prostate Cancer.
    Quayle L; Ottewell PD; Holen I
    Curr Cancer Drug Targets; 2015; 15(6):469-80. PubMed ID: 25968899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone secreted factors induce cellular quiescence in prostate cancer cells.
    Yu-Lee LY; Lee YC; Pan J; Lin SC; Pan T; Yu G; Hawke DH; Pan BF; Lin SH
    Sci Rep; 2019 Dec; 9(1):18635. PubMed ID: 31819067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tumor dormancy and identification of therapeutic targets].
    Li CF; Cao S; Meng SD
    Ai Zheng; 2009 May; 28(5):555-8. PubMed ID: 19624889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophagy pathway is required for IL-6 induced neuroendocrine differentiation and chemoresistance of prostate cancer LNCaP cells.
    Chang PC; Wang TY; Chang YT; Chu CY; Lee CL; Hsu HW; Zhou TA; Wu Z; Kim RH; Desai SJ; Liu S; Kung HJ
    PLoS One; 2014; 9(2):e88556. PubMed ID: 24551118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of disseminated tumor cells in the bone marrow of patients with operable primary breast cancer: a long-term follow-up study.
    Domschke C; Diel IJ; Englert S; Kalteisen S; Mayer L; Rom J; Heil J; Sohn C; Schuetz F
    Ann Surg Oncol; 2013 Jun; 20(6):1865-71. PubMed ID: 23263703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of circulating tumor cells (CTC) in peripheral blood and disseminated tumor cells in the bone marrow (DTC-BM) of breast cancer patients.
    Schindlbeck C; Andergassen U; Hofmann S; Jückstock J; Jeschke U; Sommer H; Friese K; Janni W; Rack B
    J Cancer Res Clin Oncol; 2013 Jun; 139(6):1055-62. PubMed ID: 23525580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer.
    Berezovska OP; Glinskii AB; Yang Z; Li XM; Hoffman RM; Glinsky GV
    Cell Cycle; 2006 Aug; 5(16):1886-901. PubMed ID: 16963837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.